|
Keywords :English - QXCI,
energetic Medicine, Electroacupuncture, EAV, Bioresonance, Bicom, BFD, Vega,
Vegatest, Bioresonance therapie, Quantum, Xrroid, bioenergetic, Energy medicine,
bioenergetic, Life energy, Reinhold Voll, Rife, Rife-Therapy, Bill Nelson,
regulation medicine, regulation diagnostic, Phazyx, Kindling, Computron,
Dermatron, remedy testing, magnet therapy, cybernetic loop, resonant frequency,
trivector, bioinformation, bioinformation therapy, subtle energy, vibrational
energy, TENS, energyscan, biofeedback, bio-feedback, electrodermal screening
Keywords: Deutsch - QXCI, energetische Medizin,
Elektroakupunktur, EAV, Bioresonanz, Bicom, BFD,
Vega, Vegatest, Bioresonaztheraphie, Quantum, Xrroid, Bioenergetik,
Energiemedizin, bioenergetisch, Lebensenergie, Reinhold Voll, Rife,
Rife-Therapie, Bill Nelson, Regulationsmedizin, Regulationsdiagnostik, Phazyx,
Kindling, Computron, Dermatron, Medikamententestung, Magnettherapie, Cybernetic
Loop, Resonanzfrequenz, Trivektor
Back to Treatment
DataBase "Table of contens"
AIDS
1.QXCI Treatment Possibilities
1.1.
Immune System related treatment
Ø
Click Programs
(from menu bar on top of main test screen)
Ø
Click Spinal
and Sarcodes (from drop down menu)
Ø
Click Timed
Therapies
(from middle of page)
Ø
Select
treatment time by moving bar
Ø
Optionally
select or unselect any additional treatment
Ø
Click Spleen (from first column)
Ø
To close
click on OK in “Therapy Over” window and then click Close
Ø
Click Immune
Stim
(from third column)
Ø
To close
click on OK in “Therapy Over” window and then click Close
Ø
Click Programs
(from menu bar on top of main test screen
Ø
Click Timed
Therapy Music Superlearning (from
drop down menu)
Ø
For best
results have patient focus mind on “Area of Concern”
Ø
Click Timed
Treatments (from
middle of page)
Ø
Click Overall
immune Stimulation
Ø
To close
click on OK in “Therapy Over” window and then click Close
Ø
Click Programs
(from menu bar on top of main test screen)
Ø
Click Biofeedback (from drop down menu)
Ø
Click Additional
(from menu bar on top of biofeedback screen)
Ø
Have
patient look at screen and focus mind on “area of concern”
Ø
Click Spleen
(from drop down menu)
Ø
To stop
click STOP PROGRAM (from upper right corner)
Ø
Click WBC
Immunity (from
drop down menu)
Ø
To stop
click STOP PROGRAM (from upper right corner)
1.2.
Detox related treatment
Ø
Click Programs
(from menu bar on top of main test screen)
Ø
Click Spinal
and Sarcodes (from drop down menu)
Ø
Click Lymph
(middle left of page)
Ø
Add an
Additional therapy superimposed (by selecting or un-selecting above and on left side)
Ø
Click
Start
Treatment
Ø
Click Programs
(from menu bar on top of main test screen)
Ø
Click Spinal
and Sarcodes (from drop down menu)
Ø
Click Timed
Therapies
(from middle of page)
Ø
Select
treatment time by moving bar
Ø
Optionally
select or unselect any additional treatment
Ø
Click Congested
Lymph Stim
(from first column)
Ø
To close
click on OK in “Therapy Over” window and then click Close
Ø
Click Sluggish
Liver Stim
(from first column)
Ø
To close
click on OK in “Therapy Over” window and then click Close
Ø
Click Programs
(from menu bar on top of main test screen)
Ø
Click Biofeedback (from drop down menu)
Ø
Click Organ
Systems (from
menu bar on top of biofeedback screen)
Ø
Have
patient look at screen and focus mind on “area of concern”
Ø
Click Lymph
(from drop down menu)
Ø
To stop
click STOP PROGRAM (from upper right corner)
2. General Information
Acquired Immune Deficiency Syndrome (AIDS)
(See also Kaposi's Sarcoma and Pneumocystis
carinii Pneumonia)
--A terminal, secondary immunodeficiency
syndrome characterized by dysfunction of cell-mediated immunity and manifested
by opportunistic infections and malignancies.
Causes and Incidence The cause is
thought to be one of several related retroviruses (human immunodeficiency virus,
or HIV) that convert viral RNA into a proviral DNA copy, which is incorporated
into the DNA of the host cell. The proviral copy then is duplicated with normal
cellular genes during each cellular division. HIV is a blood-borne virus and
commonly is transmitted through exchange of body fluids during sexual contact,
through parenteral exposure or fetal exposure to blood, and through select body
fluids from an individual infected with HIV. Infants are at risk of acquiring
the HIV during fetal development, delivery, or breast-feeding from an
HIV-positive mother. High-risk behavior for HIV exposure includes unprotected
sexual activity and IV drug use with shared needles. Occupational transmission
to health care workers is possible through needle sticks or other exposure to
HIV-infected blood. Individuals infected with HIV who are asymptomatic are in a
carrier state and may transmit the disease without displaying any of the
characteristic signs of AIDS.
AIDS is a global pandemic, and it is predicted
that more than 110 million people worldwide will be infected with HIV by the end
of the century. As of 1991 more than 1.1 million people worldwide had died.
In the United States the incidence of AIDS has
steadily increased from 3.46 per 100,000 population in 1985 to 40.20 per 100,000
population in 1993. Although it is far too early to interpret the reasons, in
1994 the incidence of reported AIDS cases dropped slightly, to 30.07 per 100,000
population. All races and ethnic groups are affected. Currently men far
outnumber women as victims of the disease. However, the fastest rise in cases is
occurring among minority women. The median age range for all individuals with
AIDS is 30 to 39 years.
Disease Process The current theory
holds that as HIV is reproduced, it affects the immune system by infecting the
T-helper cell lymphocytes, which usually coexist in a 2:1 ratio with
T-suppressor cells. As the viruses replicate, masquerading as helper cells, the
number of real helper cells declines, and the T-suppressor cells eventually
dominate, leading to immunosuppression and a lowering of the body's prime
defense mechanism against intracellular pathogens and the formation of malignant
tumors.
Symptoms AIDS is a chronic,
progressive, terminal illness that can be divided into four stages, as defined
by the federal Centers for Disease Control and Prevention (CDC):
Stage I
An acute, flulike syndrome that develops at
the time of initial infection and lasts from days to weeks
Stage II
An asymptomatic, HIV-positive carrier state
that may persist for years
Stage III
Generalized, persistent lymphadenopathy
Stage IV
The development of other disease processes,
including (1) constitutional disease (weight loss greater than 10% of body
weight, persistent diarrhea, fever, malaise, oral thrush); (2) neurologic
disease (peripheral neuropathies, paresthesia, myelopathy, dementia); (3)
opportunistic infections (bacterial, viral, fungal, or protozoal) and their
accompanying clinical features; (4) secondary neoplasms; and (5) other
conditions (e.g., endocarditis, interstitial pneumonitis, immune
thrombocytopenic purpura)
Potential Complications The
complications are numerous and are associated with the various opportunistic
infections or neoplasms, as well as the repetitive nature of the infections.
These infections eventually overwhelm the body's compromised immune system,
leading to massive infectious invasions in every body system and, eventually,
death.
Diagnostic Tests
Clinical evaluation
Any of the above manifestations; history of
high-risk behavior
Enzyme-linked immunosorbent assay (ELISA)
Screening test for HIV antibody (may be
positive from 0 to 12 months after exposure)
Western blot/ immunofluorescent assay
To confirm reactive seropositive results
obtained by ELISA test
WBCs/lymphocytes
Depressed
T-cell studies
Reduced reactivity and function of T cells;
reduced number of T-helper cells, increased number of T-suppressor cells
B-cell studies
Numbers and function normal or increased
Natural killer (NK) cells
Reduced activity
Complement
Normal or increased
Treatments
Surgery
Tumor excision of some related neoplasms
Drugs
Experimental treatment with various retroviral
drugs such as zidovudine (Retrovir; formerly azidothymidine [AZT]); didanosine
(Videx; formerly dideoxyinosine [ddI]; and zalcitabine (Hivid; formerly
dideoxycytidine [ddC]), using CD4 lymphocyte counts as a treatment guide;
prophylaxis with trimethoprim-sulfamethoxazole tablets to prevent Pneumocystis
carinii pneumonia (PCP); rifabutin prophylaxis for Mycobacterium avium infection;
drugs specific for various opportunistic infections; chemotherapy for
carcinomas; prophylactic use of zidovudine following exposure through
penetrating injuries is controversial
General
Measures to improve overall health (e.g., no
smoking, balanced nutrition, drug rehabilitation, flu vaccine, pneumococcal
vaccine, hepatitis B vaccine); supportive measures for coping with and adapting
to the effects of the disease (e.g., counseling, support groups); instruction in
how the disease is spread in order to promote prevention, particularly among
high-risk groups; use of universal precautions by health care workers and family
members to prevent transmission
| 